Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.20p
   
  • Change Today:
      0.050p
  • 52 Week High: 11.85p
  • 52 Week Low: 3.82p
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 1,526,850
  • Market Cap: £22.40m

Eden partner launches first products using its encapsulation technology

By Natasha Roberts

Date: Tuesday 22 Apr 2014

LONDON (ShareCast) - AIM-listed natural micro-encapsulation company, Eden Research, on Tuesday announced that its licensee, TerpeneTech, has launched two pet odour neutralising products for companion animals in France.

Both products make use of Eden's encapsulation technology, marking the first-ever commercial launch of products using Eden's intellectual property (IP) in encapsulation.

The two products, YP Odor Control Formula and YP Odor Control Seborrhea, will initially be distributed in France by Laboratoires Agecom under its E Lotion brand before being distributed in other territories around the world. Both products are natural products that neutralise bad odours on dogs and cats.

TerpeneTech has a licence agreement with Eden for the use of Eden's patented encapsulation technology in consumer and agricultural related biocides. Under the agreement, Eden will receive royalty income on the net sales of the product on an ongoing basis.

Clive Newitt, the Managing Director of Eden, said: "The first commercial launch of products using our IP is a key milestone for the company and introduces the first stream of royalty revenues to the company.

"The strategy of licensing our technology and receiving a royalty on product sales allows Eden to benefit from the development and commercialisation of these products by companies who have expertise in their particular market sector. We expect to see further revenues generated through royalties as more of our licensees bring their products to market in the near future."

NR

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Eden Research Market Data

Currency UK Pounds
Share Price 4.20p
Change Today 0.050p
% Change 1.20 %
52 Week High 11.85p
52 Week Low 3.82p
Volume 1,526,850
Shares Issued 533.35m
Market Cap £22.40m

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.37% below the market average17.37% below the market average17.37% below the market average17.37% below the market average17.37% below the market average
29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average
Price Trend
21.6% below the market average21.6% below the market average21.6% below the market average21.6% below the market average21.6% below the market average
16.98% above the sector average16.98% above the sector average16.98% above the sector average16.98% above the sector average16.98% above the sector average
Income Not Available
Growth
49.00% above the market average49.00% above the market average49.00% above the market average49.00% above the market average49.00% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average

Eden Research Dividends

No dividends found

Trades for 14-Jun-2024

Time Volume / Share Price
15:59 596,915 @ 4.40p
15:05 459,563 @ 4.35p
14:52 7,933 @ 4.08p
14:46 12,737 @ 4.08p
14:37 13,833 @ 3.82p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page